Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

Kapoor, R; Furby, J; Hayton, T; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; Hughes, RAC; Miller, DH; (2010) Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet neurology, 9 (7). pp. 681-688. ISSN 1474-4422 DOI: https://doi.org/10.1016/S1474-4422(10)70131-9

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1474-4422(10)70131-9

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar